Sagar Vitaceuticals has expanded its manufacturing footprint with the commissioning of a new state-of-the-art facility in Ogun State, marking a significant step in the company's commitment to making quality medicines more widely available.

Expanding capacity to meet demand

The new plant, commissioned in August 2023, increases the company's production capacity across its core dosage forms:

• Tablets
• Capsules
• Liquids
• Ointments
• Dry powder sachets

The expansion allows Sagar Vitaceuticals to serve a growing number of healthcare providers and patients across the region with a more reliable supply.

Built on quality

The facility has been designed around current Good Manufacturing Practice (GMP) principles, with controlled production environments, modern equipment and documented quality systems at every stage, from raw material intake to finished product release.

Looking ahead

"This facility reflects our long-term commitment to quality, access and growth," said a company representative. "We will continue to invest in the people, processes and technology that help us deliver medicines healthcare professionals can trust."

For enquiries about our products or partnership opportunities, please contact the Sagar Vitaceuticals team.